Close Menu

NEW YORK (GenomeWeb) – 23andMe is one of the most recognized brands in consumer genetics and the only company in the space to have submitted its health risk tests for US Food and Drug Administration scrutiny. Yet, the public health concerns that have trailed the company since its inception aren't going away.

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.